BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19206452)

  • 1. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.
    Ajima K; Murakami T; Mizoguchi Y; Tsuchida K; Ichihashi T; Iijima S; Yudasaka M
    ACS Nano; 2008 Oct; 2(10):2057-64. PubMed ID: 19206452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon nanohorns as anticancer drug carriers.
    Ajima K; Yudasaka M; Murakami T; Maigné A; Shiba K; Iijima S
    Mol Pharm; 2005; 2(6):475-80. PubMed ID: 16323954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum hole-opening condition for Cisplatin incorporation in single-wall carbon nanohorns and its release.
    Ajima K; Maigné A; Yudasaka M; Iijima S
    J Phys Chem B; 2006 Oct; 110(39):19097-9. PubMed ID: 17004753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
    Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
    Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
    Hirai M; Minematsu H; Hiramatsu Y; Kitagawa H; Otani T; Iwashita S; Kudoh T; Chen L; Li Y; Okada M; Salomon DS; Igarashi K; Chikuma M; Seno M
    Int J Pharm; 2010 May; 391(1-2):274-83. PubMed ID: 20211714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile.
    Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J
    Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
    Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
    Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.
    Murakami T; Sawada H; Tamura G; Yudasaka M; Iijima S; Tsuchida K
    Nanomedicine (Lond); 2008 Aug; 3(4):453-63. PubMed ID: 18694307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of a fosfomycin combination on the anti-tumor effect of CDDP].
    Sagara N; Nakano K; Aizawa M; Hara S; Inufusa H; Mori N; Kurooka K; Haeno Y; Yasutomi M
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):97-100. PubMed ID: 3337531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
    Chiang CS; Tseng YH; Liao BJ; Chen SY
    Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice.
    Takeda A; Tsuchiya H; Tajino T; Kikuchi S
    Anticancer Res; 2005; 25(4):2777-84. PubMed ID: 16080526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.
    Chaudhuri P; Soni S; Sengupta S
    Nanotechnology; 2010 Jan; 21(2):025102. PubMed ID: 19955607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New application of carbon nanotubes in haemostatic dressing filled with anticancer substance.
    Nowacki M; Wiśniewski M; Werengowska-Ciećwierz K; Terzyk AP; Kloskowski T; Marszałek A; Bodnar M; Pokrywczyńska M; Nazarewski Ł; Pietkun K; Jundziłł A; Drewa T
    Biomed Pharmacother; 2015 Feb; 69():349-54. PubMed ID: 25661381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice.
    Ye H; Jin L; Hu R; Yi Z; Li J; Wu Y; Xi X; Wu Z
    Biomaterials; 2006 Dec; 27(35):5958-65. PubMed ID: 16949149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel.
    Konishi M; Tabata Y; Kariya M; Hosseinkhani H; Suzuki A; Fukuhara K; Mandai M; Takakura K; Fujii S
    J Control Release; 2005 Mar; 103(1):7-19. PubMed ID: 15710496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
    Nishita T
    Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model.
    Podesta JE; Al-Jamal KT; Herrero MA; Tian B; Ali-Boucetta H; Hegde V; Bianco A; Prato M; Kostarelos K
    Small; 2009 May; 5(10):1176-85. PubMed ID: 19306454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J; Pang X; Yu K; Liu L; Zhou J
    Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.